David Shera is a biostatistician with extensive experience in both academic and industry settings within biomedical research. They have served as an adjunct professor at Drexel University and have held significant positions at renowned organizations, including Merck & Co., Inc., and Massachusetts General Hospital. Currently, David is an Associate Principal Scientist in Oncology Biometrics at AstraZeneca, focusing on ctDNA as a cancer biomarker. Their contributions span numerous projects and publications, showcasing a strong aptitude for quantitative problem-solving and data analysis across various stages of research. David's educational background includes advanced degrees in biostatistics and mathematics from Harvard University, MIT, and Rice University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices